The Valley Desk

NCT06433752 · Observational study

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Overall registry status Recruiting

Conditions Multiple Sclerosis, Relapsing Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov